Latest Innovation News

CAR Group has reported robust half-year results for FY25, showcasing strong revenue and earnings growth across its global markets, underpinned by strategic diversification and innovation.

CAR Group Ltd reported a robust half-year performance for the period ending December 31, 2024, with revenue up 9% and profit growth across all key markets. The company declared a 38.5 cents per share interim dividend, underscoring its strong financial position and confidence in future growth.

Mount Hope Mining Limited has confirmed robust copper, lead, silver, and zinc mineralisation at its Mount Hope Project through a recent soil survey, reinforcing the project's exploration potential ahead of planned drilling.

Ansell Limited delivered a robust FY25 half-year performance, marked by double-digit sales and earnings growth, successful KBU acquisition integration, and an upward revision of adjusted EPS guidance.

Ansell Limited reports robust FY25 half-year results, driven by strong organic sales and EBIT growth, while accelerating its KBU integration and productivity initiatives.

Flagship Investments Limited posted a solid 9.1% gain in its investment portfolio for the half-year ending December 2024, despite a notable decline in total comprehensive income. The company declared a fully franked interim dividend of 5.1 cents per share, reflecting steady shareholder returns.

NT Minerals Limited reveals promising initial assay results from its Ultrafine Soil Sampling Program at the Twin Peaks Project, highlighting significant copper and gold anomalism that paves the way for targeted drilling in 2025.

Neuren Pharmaceuticals has received a significant cash inflow of approximately US$50 million following the sale of a Priority Review Voucher linked to its Rett syndrome treatment. This milestone underscores the growing value of Neuren’s neurological drug portfolio and its partnership with Acadia Pharmaceuticals.

Nyrada has secured ethics approval to begin its first-in-human Phase Ia trial of NYR-BI03, a promising neuro- and cardioprotective drug candidate. Recruitment starts soon, with dosing expected by March and results due in Q3 2025.

Opyl Limited has entered a strategic partnership with Avion, integrating its AI-powered TrialKey platform to enhance clinical trial design and execution across the APAC region.

RLF AgTech Ltd has successfully raised approximately $2.42 million through an Entitlement Issue and Shortfall Placement, reflecting strong shareholder confidence in its turnaround strategy and growth prospects in Australia and Asia.

Acrux Limited announces the retirement of CEO Michael Kotsanis after more than 10 years at the helm, with a search underway for his successor to lead the next phase of growth.